2025-523601-16-00招募中1 期
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 154
- 试验地点
- 16
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Eli Lilly & Co.
Scientific
Eli Lilly & Co.
研究点 (16)
Loading locations...
相似试验
招募中
1 期
A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid ArthritisRheumatoid arthritis (RA)2025-523980-39-00Eli Lilly & Co.15
招募中
1 期
A Study of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver Impairment2025-521947-19-00Eli Lilly & Co.26
招募中
1 期
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors (FiREBOLT)Ovarian Neoplasms
Breast Neoplasms
Pancreatic Intraductal Neoplasms
Colorectal Neoplasms
Esophageal Neoplasms
Stomach Neoplasms
CholangiocarcinomaOvarian Neoplasms Breast Neoplasms Pancreatic Intraductal Neoplasms Colorectal Neoplasms Esophageal Neoplasms Stomach Neoplasms Cholangiocarcinoma2025-521887-37-00Eli Lilly & Co.64
招募中
1 期
A Phase 1 Study on the effects of LY3410738 (study drug) administered to Patients with Advanced Solid Tumors with IDH1 or IDH2 Mutations2024-515150-24-00Eli Lilly & Co.3
招募中
1 期
A Phase 1 Study of PRT12396 in Participants with Select Myeloproliferative NeoplasmsPost-Essential Thrombocythemia MyelofibrosisPost-Polycythemia Vera MyelofibrosisIntermediate-1, Intermediate-2, or High-Risk Primary MyelofibrosisHigh-risk Polycythemia Vera2026-525484-40-00Prelude Therapeutics Inc.22